Gyre Therapeutics
GYRE
GYRE
42 hedge funds and large institutions have $36.5M invested in Gyre Therapeutics in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
50% less call options, than puts
Call options by funds: $15K | Put options by funds: $30K
54% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 13
Holders
42
Holding in Top 10
2
Calls
$15K
Puts
$30K
Top Buyers
| 1 | +$2.26M | |
| 2 | +$1.18M | |
| 3 | +$658K | |
| 4 |
FM
Fondren Management
Houston,
Texas
|
+$439K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$100K |
Top Sellers
| 1 | -$1.4M | |
| 2 | -$929K | |
| 3 | -$471K | |
| 4 |
Goldman Sachs
New York
|
-$440K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$325K |